Clinical Trial Update: Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of sorafenib with capecitabine and oxaliplatin in advanced or metastatic hepatocellular carcinoma. The document notes t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: The University of Hong Kong | Conditions: Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN